Dr. Paul D. Herman, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1995 Errecart Blvd, Suite 110, Elko, NV 89801 Phone: 775-777-2210 Fax: 775-777-1113 |
Hannah Taft, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1993 Errecart Blvd, Elko, NV 89801 Phone: 775-753-1049 |
Karen L Wright, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 845 Railroad St, Elko, NV 89801 Phone: 775-385-4377 Fax: 866-595-5411 |
Dr. Terry J Nevins, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 762 14th St, Elko, NV 89801 Phone: 775-738-5850 Fax: 775-738-5856 |
Kirin Leslie Madden, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 515 Shoshone Cir, Elko, NV 89801 Phone: 775-738-2252 Fax: 775-738-4219 |
Dr. Ronald David Simon, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1995 Errecart Blvd, Suite 208, Elko, NV 89801 Phone: 775-777-8008 Fax: 775-996-4318 |
Dr. Steve Lore, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 762 14th St, Elko, NV 89801 Phone: 775-738-5850 Fax: 775-753-7190 |
News Archive
Medicare's massive drug program continues to be in the news, from a report finding that it fails to adequately track fraud, to continued opposition to an administration proposal that would revamp the program.
ViroPharma Incorporated today announced the launch of 'Ryze Above' (www.ryzeabove.com), an exclusive patient resources program within the company's patient support program, CINRYZESolutions®. The Ryze Above program was created for HAE patients prescribed Cinryze, the first and only drug specifically approved to help prevent swelling and/or painful attacks in teenagers and adults with HAE.
Hologic, Inc. (Hologic or the Company), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the U.S. Food and Drug Administration (FDA) cleared the Company's 510K application for the MammoSite((R)) ML radiation therapy system.
AbbVie released preliminary results from an ongoing Phase I study with ABT-414, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody drug conjugate, in combination with temozolomide, which showed four objective responses, including one complete response, in patients with recurrent or unresectable glioblastoma multiforme.
Align Technology, Inc. and Cadent, Inc., today announced an agreement to jointly develop software applications that will run on Cadent iTero and iOC scanners for use in Invisalign treatment. The new applications will optimize case assessment and planning for Invisalign treatment, and bring valuable digital tools chair-side for Invisalign providers who use Cadent scanners.
› Verified 7 days ago